Cleared Traditional

K870075 - CENTRAL VENOUS CATHETER

K870075 is an FDA 510(k) clearance for CENTRAL VENOUS CATHETER, manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 109-day FDA review.

K870075 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1987
Decision
109d
Days
Class 2
Risk

K870075 is an FDA 510(k) clearance for the CENTRAL VENOUS CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Franklin Lakes, US). The FDA issued a Cleared decision on April 27, 1987 after a review of 109 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Bd Becton Dickinson Vacutainer Systems Preanalytic devices

FDA 510(k) Submission Details - K870075

510(k) Number K870075 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 08, 1987
Decision Date April 27, 1987
Days to Decision 109 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
16d faster than avg
Panel avg: 125d · This submission: 109d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 822
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K870075.
J-CATH, GISH MODEL NO. JVAC-XXXX
K863790 · Gish Biomedical, Inc. · Jun 1987
ACS ENHANCED-TORQUE CORONARY GUIDING CATHETER
K871425 · Advanced Cardiovascular Systems, Inc. · May 1987
MULTICATH - CODE#S 8.1207.OO/8.1208.00/8.1205.20
K870067 · Vygon Corp. · Apr 1987
MEDI-TECH SELECTIVE TORQUE CATHETER
K864118 · Medi-Tech, Inc. · Apr 1987
ADDITIONAL 13.4CM. FRENCH CATHETER INSERTION TRAY
K870675 · Quinton, Inc. · Apr 1987
URESIL SUBCLAVIAN CATHETER
K863684 · Uresil Corp. · Jan 1987